Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Receptos, Inc. (NASDAQ:RCPT.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RCPT.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

XMFmoatster (98.86)
Submitted June 19, 2015

Acquisition target plus multi-billion dollar drug in phase 3 that could be approved per "some" wall-st analysts viz. Wedbush whose bullish notes were featured in Barrons.Might be more valuable in CAPS for me if it remained stand alone and got the… More

MMCapitalMgmt (95.97)
Submitted October 31, 2014

Company is burning through cash like crazy without generating any sales, and therefore, cash flow.

NASDAQ:RCPT.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about RCPT.DL.

No one has written a Pitch for RCPT.DL stock yet. Tell us why you think RCPT.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in RCPT.DL.

No players have picked RCPT.DL yet. Tell us why you think RCPT.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RCPT.DL.